Irsin-2 has an inhibitory effect on the development of osteoporosis by increasing the number and activity of osteoblasts and suppressing sclerostin (Sost), which has an inhibitory effect on the formation of new bone [82]. This evidence concerns the gene SOST and osteoporosis.